Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Ultrasound
Published in: Cardiovascular Ultrasound 1/2008

Open Access 01-12-2008 | Review

Echocardiography in the diagnosis left ventricular noncompaction

Author: Ze-Zhou Song

Published in: Cardiovascular Ultrasound | Issue 1/2008

Login to get access

Abstract

Echocardiography is the method of choice to establish a diagnosis and determine a treatment plan for patients with noncompaction of ventricular myocardium (NVM). The 2-dimentional echocardiography, 3-dimentional echocardiography, color Doppler echocardiography and contrast-enhanced echocardiography are of critical importance for diagnosis and family screening of NVM.
Appendix
Available only for authorised users
Literature
1.
Boyd MT, Seward JB, Tajik AJ, Edwards WD: Frequency and location of prominent left ventricular trabeculations at autopsy in 474 normal human hearts: implications for evaluation of mural thrombi by two-dimensional echocardiography. J Am Coll Cardiol. 1987, 9: 323-326.CrossRefPubMed
2.
Sedmera D, Pexieder T, Vuillemin M, Thompson RP, Anderson RH: Developmental patterning of the myocardium. Anat Rec. 2000, 258: 319-337.CrossRefPubMed
3.
Maron BJ, Towbin JA, Thiene G, Antzelevich C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB: AHA Scientific Statement. Contemporary Definition and Classification of the Cardiomyopathies. Circulation. 2006, 113: 1807-1816.CrossRefPubMed
4.
Weiford BC, Subbarao VD, Mulhern KM: Noncompaction of the ventricular myocardium. Circulation. 2004, 109: 2965-2971.CrossRefPubMed
5.
Lowery MH, Martel JA, Zambrano JP, Ferreira A, Eco L, Gallagher A: Noncompaction of the ventricular myocardium: The use of contrast-enhanced echocardiography in diagnosis. J Am Soc Echocardiogr. 2003, 16: 94-96.CrossRefPubMed
6.
Soler R, Rodriguez E, Monserrat L, Alvarez N: MRI of subendocardial perfusion deficits in isolated left ventricular noncompaction. J Comput Assist Tomogr. 2002, 26: 373-375.CrossRefPubMed
7.
Petersen SE, Selvanayagam JB, Wiesmann F, Robson MD, Francis JM, Anderson RH, Watkins H, Neubauer S: Left ventricular non-compaction. Insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005, 46: 101-105.CrossRefPubMed
8.
Jenni R, Oechnlin E, Schneider J, Jost CA, Kaufman PA: Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001, 86: 666-671.CrossRefPubMedPubMedCentral
9.
Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R: Isolated noncompaction of left ventricular myocardium: a study of eight cases. Circulation. 1990, 82: 507-513.CrossRefPubMed
10.
Božić I, Fabijanić D, Carević V, Polić S: Echocardiography in the diagnosis and management of isolated left ventricular noncompaction: case reports and review of the literature. J Clin Ultrasound. 34: 416-421.
11.
Toyono M, Kondo C, Nakajima Y, Nakazawa M, Momma K, Kusakabe K: Effects of carvedilol on left ventricular function, mass, and scintigraphic findings in isolated left ventricular non-compaction. Heart. 2001, 86: E4-CrossRefPubMedPubMedCentral
12.
Ichida F, Hamamichi Y, Miyawaki T, Ono Y, Kamiya T, Akagi T, Hamada H, Hirose O, Isobe T, Yamada K, Kurotobi S, Mito H, Miyake T, Murakami Y, Nishi T, Shinohara M, Seguchi M, Tashiro S, Tomimatsu H: Clinical features of isolated noncompaction of the ventricular myocardium. J Am Coll Cardiol. 1999, 34: 233-240.CrossRefPubMed
13.
Baker GH, Pereira NL, Hlavacek AM, Chessa K, Shirali G: Transthoracic Real-Time Three-Dimensional Echocardiography in the Diagnosis and Description of Noncompaction of Ventricular Myocardium. Echocardiography. 2006, 23: 490-494.CrossRefPubMed
14.
Main ML, Grayburn PA: Clinical applications of transpulmonary contrast echocardiography. Am Heart J. 1999, 137: 144-153.CrossRefPubMed
15.
Mulvagh SL, DeMaria AN, Feinstein SB, Burns PN, Kaul S, Miller JG, Monaghan M, Porter TR, Shaw LJ, Villanueva FS: Contrast echocardiography: Current and future applications. American Society of Echocardiography Task Force on Standards and Guidelines for the use of Ultrasonic Contrast in Echocardiography. J Am Soc Echocardiogr. 2000, 13: 331-342.CrossRefPubMed
16.
Koo BK, Choi D, Ha JW, Kang SM, Chung N, Cho SY: Isolated Noncompaction of the Ventricular Myocardium: Contrast Echocardiographic Findings and Review of the Literature. Echocardiography. 2002, 19: 153-156.CrossRefPubMed
17.
Hayashi Y, Hamada M, Hiwad K: Characterization of left ventricular opaci.cation using sonicated serum albumin in patients with dilated cardiomyopathy and myocardial infarction. Jpn Circ J. 1998, 62: 91-96.CrossRefPubMed
18.
Bednarz JE, Spencer KT, Weinert L, Sugeng L, Mor-Avi V, Lang RM: Identification of cardiac masses and abnormal blood flow patterns with harmonic power-Doppler contrast echocardiography. J Am Soc Echcardiogr. 1999, 12: 871-875. 10.1016/S0894-7317(99)70195-1.CrossRef
19.
Oechslin E, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R: Long-term follow-up of 34 adults with isolated left ventricular non-compaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000, 36: 493-497.CrossRefPubMed
20.
Conces DJ, Ryan T, Tarver RD: Noncompaction of ventricular myocardium: CT appearance. Am J Roentgenol. 1991, 156: 717-718.CrossRef
21.
Junga G, Kneifel S, Von Smekal A, Steinert H, Bauersfeld U: Myocardial ischemia in children with isolated ventricular non-compaction. Eur Heart J. 1999, 20: 910-916.CrossRefPubMed
22.
Daimon Y, Watanabe S, Takeda S, Hijikata Y, Komuro I: Two-layered appearance of noncompaction of the ventricular myocardium on magnetic resonance imaging. Circ J. 2002, 66: 619-621.CrossRefPubMed
23.
Hany TF, Jenni R, Debatin JF: MR appearance of isolated noncompaction of the left ventricle. J Magn Reson Imaging. 1997, 7: 437-CrossRefPubMed
Metadata
Title
Echocardiography in the diagnosis left ventricular noncompaction
Author
Ze-Zhou Song
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2008
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-6-64

Other articles of this Issue 1/2008

Cardiovascular Ultrasound 1/2008 Go to the issue

Research

Head to head comparison of 2D vs real time 3D dipyridamole stress echocardiography

Research

Feasibility and diagnostic power of transthoracic coronary Doppler for coronary flow velocity reserve in patients referred for myocardial perfusion imaging

Research

Understanding atrioventricular septal defect: Anatomoechocardiographic correlation

Technical notes

Flow-volume loops derived from three-dimensional echocardiography: a novel approach to the assessment of left ventricular hemodynamics

Research

Circumferential 2D-strain imaging for the prediction of long term response to cardiac resynchronization therapy

Case report

Echocardiographic manifestation of hiatus hernia simulating a left atrial mass: Case report
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits